Porphyrins for boron neutron capture therapy
Patent
·
OSTI ID:867537
- Center Moriches, NY
- Bremen, DE
Novel compounds for treatment of brain tumors in Boron Neutron Capture Therapy are disclosed. A method for preparing the compounds as well as pharmaceutical compositions containing said compounds are also disclosed. The compounds are water soluble, non-toxic and non-labile boronated porphyrins which show significant uptake and retention in tumors.
- Research Organization:
- ASSOC UNIVERSITIES INC
- DOE Contract Number:
- AC02-76CH00016
- Assignee:
- United States of America as represented by United States (Washington, DC)
- Patent Number(s):
- US 4959356
- OSTI ID:
- 867537
- Country of Publication:
- United States
- Language:
- English
Similar Records
Porphyrins for boron neutron capture therapy
Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy
Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy
Patent
·
1990
·
OSTI ID:5774012
Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy
Patent
·
1995
·
OSTI ID:870091
Halogenated sulfidohydroboranes for nuclear medicine and boron neutron capture therapy
Patent
·
1997
·
OSTI ID:870870
Related Subjects
/424/999/
boron
boron neutron
boronated
boronated porphyrins
brain
brain tumors
capture
capture therapy
compositions
compositions contain
compositions containing
compounds
containing
disclosed
method
neutron
neutron capture
non-labile
non-toxic
novel
novel compound
novel compounds
pharmaceutical
pharmaceutical composition
pharmaceutical compositions
porphyrins
preparing
retention
significant
soluble
therapy
treatment
tumors
uptake
water
water soluble
boron
boron neutron
boronated
boronated porphyrins
brain
brain tumors
capture
capture therapy
compositions
compositions contain
compositions containing
compounds
containing
disclosed
method
neutron
neutron capture
non-labile
non-toxic
novel
novel compound
novel compounds
pharmaceutical
pharmaceutical composition
pharmaceutical compositions
porphyrins
preparing
retention
significant
soluble
therapy
treatment
tumors
uptake
water
water soluble